Eli Lilly and CompanyvsSolventum

LLY and SOLV stock compared: price, dividend, valuation and results, from SEC filings.

LLY

Eli Lilly and Company

$1,407.62

Value $1.33T

-1.64%
LLY's page

SOLV

Solventum Corporation

$87.61

Value $15.2B

-1.17%
SOLV's page

Eli Lilly and Company (LLY) has a market value of $1.33T and Solventum (SOLV) $15.2B. Over the last year, with dividends, LLY moved +38.2% and SOLV +15.8%. The P/E is 48.2 for LLY and 97.4 for SOLV. Dividend yield: LLY 0.45%, SOLV none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LLY$1.33T

    SOLV$15.2B

    LLY is 87 times SOLV

  • Revenue, 12 months

    LLY$86.5B

    SOLV$8.2B

    LLY is 11 times SOLV

  • Net income, 12 months

    LLY$27.6B

    SOLV$156M

    LLY is 177 times SOLV

  • Operating margin

    LLY–

    SOLV5.6%

  • ROIC

    LLY35.5%

    SOLV4.2%

    31.3 points apart

  • P/E

    LLY48.2

    SOLV97.4

    SOLV is 2.0 times LLY

  • Dividend yield

    LLY0.4%

    SOLV0.0%

    0.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LLY+38.2%

SOLV+15.8%

100120140DecFebAprJunAugOct
Returns by period
PeriodLLYWith dividendsSOLVWith dividends
1 year since November 14, 2025+38.2%Price +37.4%+15.8%Price +15.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LLYEli Lilly and CompanySOLVSolventum

Valuation

LLYSOLV
Valuation
Price$1,407.62$87.61
Market value$1.33T$15.2B
Enterprise value (EV)$1.37T$20.0B
P/E48.297.4
P/E, 5-year median49.9–
P/B33.03.2
EV/EBIT39.544.0
Free cash flow yield1.5%–

Results and growth

LLYSOLV
Results and growth
Revenue, 12 months$86.5B$8.2B
Net income, 12 months$27.6B$156M
Free cash flow, 12 months$19.7B$0
Earnings per share, 12 months$30.81$0.88
Revenue growth, year on year44.7%0.9%
Revenue growth a year, past+21.6%over 5 years+0.8%over 3 years
EPS growth a year, past+27.6%over 5 years+4.5%over 3 years

Margins and returns on capital

LLYSOLV
Margins and returns on capital
Gross margin83.6%54.8%
Operating margin–5.6%
Net margin31.9%1.9%
ROIC35.5%4.2%
ROE88.6%3.2%

Balance sheet

LLYSOLV
Balance sheet
Cash$4.9B$451M
Total debt$49.5B$5.3B
Net debt / EBITDA1.25.1
Interest cover38.9×–

Dividends and buybacks

LLYSOLV
Dividends and buybacks
Dividend yield0.4%–
Dividend per share, 12 months$6.34–
Dividend growth a year, past+15.2%over 5 years–
Buyback yield0.3%–
Shareholder yield0.8%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LLY or SOLV

Didn't find what you were looking for?

Ask us
Which is bigger, Eli Lilly and Company or Solventum?

By market value, Eli Lilly and Company ($1.33T) is about 87.4 times Solventum ($15.2B), at today's prices.

How did LLY and SOLV stock do over the last 1 years?

Since November 14, 2025, LLY's price moved +37.4% and SOLV's +15.8%. With dividends: LLY +38.2% (+38.2% a year), SOLV +15.8% (+15.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, LLY or SOLV?

The dividend yield at today's price is 0.45% for Eli Lilly and Company and none for Solventum. Over the last twelve months they paid $6.34 and – per share.

What is the P/E of LLY and SOLV?

At today's price, the P/E is 48.2 for LLY and 97.4 for SOLV. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Eli Lilly and Company or Solventum?

Over the last twelve months, the net margin was 31.9% for Eli Lilly and Company and 1.9% for Solventum, and the operating margin – and 5.6%. Revenue was $86.5B and $8.2B.

Which is the better investment, Eli Lilly and Company or Solventum?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.